Clorox Co. stock falls toward 52-week low as analysts stay cautious

Clorox Co. stock (ISIN US1890541097) is trading near the bottom of its yearly range, with shares closing at USD 83.17 as of September 19, 2026, only slightly above the 52-week low of USD 83.09 and well below the 52-week high of USD 128.90.

Analyst recommendations signal cautious stance

Brokerage sentiment remains subdued for Clorox Co. stock, with a consensus recommendation of Reduce and an average 12-month price target of USD 101.40 according to an analyst overview published on September 19, 2026.MarketBeat This average target implies that, from the latest close of USD 83.17, analysts see roughly USD 18.23 of potential upside, or about 21.9 percent, but still frame the shares as a name to underweight rather than a clear buy.

In a separate consumer-goods review dated September 19, 2026, Bank of America Securities maintained a Hold rating on Clorox with a price target of USD 100.00, while Citi also kept a Hold stance with a USD 97.00 target.The Globe and Mail Against the latest price of USD 83.17, the Bank of America Securities target of USD 100.00 represents about 20.2 percent upside, and Citi’s USD 97.00 implies about 16.6 percent upside, underscoring that even neutral-rated analysts see room for recovery but not a decisive rerating.

Dividend, cash flow and leverage shape fundamentals

Beyond the rating backdrop, income investors are closely watching Clorox’s dividend sustainability. A September 19, 2026 dividend-focused analysis highlights that Clorox pays a quarterly dividend of USD 1.25 per share and has increased this payout over time.Yahoo Finance At the recent share price of USD 83.37 cited in that piece for the period around September 19, 2026, this dividend level corresponds to an annualized payout of USD 5.00 per share and a dividend yield of about 6.0 percent, considerably higher than many large consumer names and largely a result of the depressed stock price.

However, the same analysis points to clear balance-sheet pressure after Clorox’s acquisition of GOJO. Total liabilities reached USD 7.54 billion, up 48.5 percent year over year, while shareholders’ equity declined to USD 252 million and cash stood at USD 143 million at the time of the reported figures.Yahoo Finance This leverage profile means that, relative to equity, liabilities are now about 29.9 times larger, an imbalance that inevitably enters analyst discussions around risk.

On the cash flow side, the figures cited show that full-year operating cash flow was USD 612 million, just above dividend payments of USD 602 million.Yahoo Finance That leaves only USD 10 million of coverage margin for the dividend over the fiscal year, a very thin buffer for a company facing higher leverage and integration tasks. The quarter ended March 2026 was also highlighted for generating negative operating cash flow of USD 122 million, a sign that short-term volatility in cash generation is real even if full-year numbers still cover the payout.

Looking ahead, the same source notes that adjusted earnings per share guidance for fiscal 2027 stands in a range of USD 5.70 to USD 6.00.Yahoo Finance At the mid-point of USD 5.85 per share, the annual dividend of USD 5.00 would represent a payout ratio of roughly 85.5 percent of adjusted EPS. For investors, the message is that fundamentals still support the dividend, but the cushion is materially thinner than in previous years, giving less room for error if integration or pricing initiatives disappoint.

Growth initiatives and pricing underpin medium-term story

A separate strategy-focused note dated September 19, 2026 argues that Clorox’s pricing actions, innovation and portfolio changes are supporting growth despite market pressures.Zacks The company has completed a major digital transformation, with a new enterprise resource planning system expected to improve planning and help reduce inventory levels over time. Additionally, the integration of GOJO is described as a driver that should boost fiscal 2027 sales, while productivity benefits from these changes are anticipated to build further into fiscal 2028.

According to earnings estimates summarized in the same report, the consensus for Clorox’s fiscal 2027 and fiscal 2028 earnings implies year-over-year growth of 6 percent and 8.9 percent respectively.Zacks From an investor perspective, this suggests that, despite the current leverage and narrow dividend coverage, the company is still expected to deliver mid-single to high-single-digit earnings growth over the next two fiscal years. The stock carries a Zacks Rank #3 (Hold), a rating that matches the cautious tone seen in other broker research and highlights a balance between risk and potential reward rather than a clear conviction call.

Clorox Co. stock trades near year low on NYSE

Clorox Co. stock is listed on the New York Stock Exchange under the ticker CLX, and recent data for September 19, 2026 shows a closing price of USD 83.17, with the shares down 2.1 percent on the day and near the one-year low of USD 83.09.MarketBeat With a one-year high of USD 128.90, this latest close places the stock roughly 35.5 percent below its 52-week peak, illustrating how far sentiment has weakened over the past year as leverage, cash flow volatility and dividend sustainability have come under closer scrutiny.

More news and analyses on Clorox Co. stock